Clinical Trials Sponsored by Jens Faber

Total 1749 results

Pneumonia Research Network on Genetic Resistance...
Charite University, Berlin, Germany; German Federal Ministry of Education and... and other collaborators

Completed

Study of Progression of Community Acquired Pneumonia in the Hospital (PROGRESS)

Pneumonia | Sepsis | Shock, Septic

Austria, Germany
Technical University of Munich
University Hospital, Essen; University of Erlangen-Nürnberg; Heinrich-Heine University... and other collaborators

Terminated

Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation (Rituximab 2006)

Renal Transplantation | Transplantation, Kidney | Chronic Allograft Nephropathy | Grafting

Germany
Harold J. Burstein, MD, PhD
Beth Israel Deaconess Medical Center; Genentech, Inc.; University of California... and other collaborators

Completed

Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer

Breast Cancer

United States
Harold J. Burstein, MD, PhD
Bristol-Myers Squibb; Massachusetts General Hospital; Dana-Farber Cancer Institute and other collaborators

Completed

Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer

Breast Cancer

United States
Fondazione IRCCS Istituto Nazionale dei Tumori,...
University of Padova; Mount Sinai Hospital, Canada; Istituto Oncologico Veneto... and other collaborators

Recruiting

Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.

Pregnancy Complications | Pregnancy Loss | Desmoid | Desmoid; Abdominal

United States, Canada, France, Italy
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center; Massachusetts General Hospital; University... and other collaborators

Withdrawn

MK-2206 for Recurrent Malignant Glioma

Malignant Glioma

United States
Sabine Mueller, MD, PhD
National Cancer Institute (NCI); Dana-Farber Cancer Institute; Mithil Prasad... and other collaborators

Recruiting

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors (PNOC023)

Glioblastoma | Recurrent Ependymoma | CNS Tumor | Diffuse Midline Glioma (DMG) | Recurrent Malignant Central Nervous System Neoplasm | Spinal Cord Glioma | Central Nervous System Tumor | World Health Organization (WHO) Grade III Glioma

United States, Switzerland
St. Jude Children's Research Hospital
Baylor College of Medicine; Children's Hospital of Philadelphia; Dana-Farber... and other collaborators

Recruiting

Investigation of the Genetics of Hematologic Diseases

Myelodysplastic Syndromes | Sickle Cell Disease | Fanconi Anemia | Severe Congenital Neutropenia | Bone Marrow Failure Syndromes | Blood Coagulation Disorder | Erythrocyte Disorder | Leukocyte Disorder | Hemostasis | Dyskeratosis Congenita | Diamond-Blackfan Anemia | Congenital Thrombocytopenia | Myeloproliferative...

United States
Dana-Farber Cancer Institute
Johns Hopkins University; M.D. Anderson Cancer Center; Mayo Clinic; University... and other collaborators

Active, not recruiting

GENetic Education Risk Assessment and TEsting Study (GENERATE)

Candidates for Hereditary Pancreatic Cancer Testing

United States
Susana M. Campos, MD
Massachusetts General Hospital; Wyeth is now a wholly owned subsidiary of Pfizer and other collaborators

Completed

AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies

Cervical Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Peritoneal Cancer

United States
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center; Massachusetts General Hospital; Beth... and other collaborators

Completed

Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma

Multiple Myeloma

United States
Massachusetts General Hospital
National Cancer Institute (NCI); Mayo Clinic; Washington University School of... and other collaborators

Recruiting

Proton or Photon RT for Retroperitoneal Sarcomas

Retroperitoneal Sarcoma

United States
Karen D. Wright, MD
National Cancer Institute (NCI); Pacific Pediatric Neuro-Oncology Consortium; Day One Biopharmaceuticals, Inc... and other collaborators

Active, not recruiting

DAY101 In Gliomas and Other Tumors

Low-grade Glioma

United States
Odense University Hospital
Charite University, Berlin, Germany; Hannover Medical School; Aarhus University... and other collaborators

Completed

Danish Cardiogenic Shock Trial (DanShock)

Acute Myocardial Infarction | Cardiogenic Shock Acute

Germany, Denmark, United Kingdom
Jena University Hospital
Medical University of Vienna; Hannover Medical School; University Hospital, Essen and other collaborators

Completed

Sepsis-Associated Purpura Fulminans International Registry - Europe (SAPFIRE)

Sepsis

Germany
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Emory University and other collaborators

Completed

Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies

Sickle Cell Disease | Hemoglobinopathies | Thalassemia

United States
New York Medical College
Johns Hopkins University; Baylor College of Medicine; University of California... and other collaborators

Recruiting

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease (NYMC-571)

Sickle Cell Disease

United States
Kaiser Permanente
Dana-Farber Cancer Institute; Columbia University; Emory University; University... and other collaborators

Active, not recruiting

Cancer Health Assessments Reaching Many (CHARM)

Hereditary Cancer Syndrome

United States
Beth Israel Deaconess Medical Center
University of Colorado, Denver; Massachusetts General Hospital; Dana-Farber Cancer... and other collaborators

Active, not recruiting

Efficacy and Safety of 500mg of Fulvestrant

Breast Cancer

United States
Patrick Y. Wen, MD
Massachusetts General Hospital; University of Pennsylvania; Brigham and Women... and other collaborators

Completed

Dose-Intense Temozolomide in Recurrent Glioblastoma

Glioblastoma | Gliosarcoma

United States
University of Aarhus
Odense University Hospital; Karolinska University Hospital; Oslo University Hospital and other collaborators

Recruiting

Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation (Occlusion-AF)

Stroke | Atrial Fibrillation

Sweden, Finland, Norway, Denmark, Germany
University of Sydney
Dana-Farber Cancer Institute; University of Southern California; Cambridge University... and other collaborators

Recruiting

Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours (P3BEP)

Germ Cell Tumor

Australia, New Zealand, United States
Bruno Minotti
Roland Bingisser, Principal Investigator, Head of Emergency Department, University... and other collaborators

Not yet recruiting

Open-Label Placebo for Non-Specific Pain in the ED (OLP_EM)

Pain, Acute
UNICANCER
Cancer Research UK; National Cancer Institute, France; Servier; Pierre Fabre Medicament and other collaborators

Recruiting

Personalized Medicine for Advanced Biliary Cancer Patients (SAFIR-ABC10)

Biliary Tract Neoplasms

France, Belgium, United Kingdom
Dana-Farber Cancer Institute
1 Million 4 Anna Foundation; Carson Sarcoma Foundation; Teaming up to Fight Childhood... and other collaborators

Completed

Palbociclib + Ganitumab In Ewing Sarcoma

Ewing Sarcoma | Ewing's Sarcoma Recurrent

United States
Beth Israel Deaconess Medical Center
M.D. Anderson Cancer Center; Massachusetts General Hospital; Sunnybrook Health... and other collaborators

Completed

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer (KHAD)

Prostate Cancer

United States, Canada
Harold J. Burstein, MD, PhD
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaborators

Completed

Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer

Breast Cancer

United States
Baylor College of Medicine
Children's Hospital of Philadelphia; Dana-Farber Cancer Institute; University... and other collaborators

Completed

Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors (BB'98)

Brain Tumors

United States
University of Wisconsin, Madison
Patient-Centered Outcomes Research Institute; M.D. Anderson Cancer Center; Alliance... and other collaborators

Completed

Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance

Breast Neoplasms

United States
Boston Medical Center
Boston University; Massachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center and other collaborators

Completed

Translating Research Into Practice (TRIP)

Cancer, Breast

United States
Technical University of Munich
Charite University, Berlin, Germany; University of Cologne; University of Hamburg-Eppendorf and other collaborators

Recruiting

Munich Long COVID Registry for Children, Adolescents, and Adults (MLC-R)

Post-COVID Condition

Germany
University of Michigan
M.D. Anderson Cancer Center; National Cancer Institute (NCI); Dana-Farber Cancer... and other collaborators

Completed

Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus

Barrett's Esophagus

United States, Canada
Beth Israel Deaconess Medical Center
Johns Hopkins University; Washington University School of Medicine; Dana-Farber... and other collaborators

Active, not recruiting

Effectiveness of Open and Robotic Prostatectomy (PROSTQA-RP2)

Prostate Cancer

United States
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center; Massachusetts General Hospital; University of Michigan... and other collaborators

Completed

Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer

Prostate Cancer

United States
University of Oxford
King's College London; Bayer; Boston Children's Hospital; Queen Mary University... and other collaborators

Completed

Translational Research in Pelvic Pain (TRiPP)

Chronic Pain | Endometriosis | Bladder Pain Syndrome

United Kingdom, Portugal
Memorial Sloan Kettering Cancer Center
University of Pennsylvania; University of California, Los Angeles; Dana-Farber... and other collaborators

Active, not recruiting

BRCA Founder OutReach (BFOR) Study (BFOR)

BRCA1 Mutation | BRCA2 Mutation

United States
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center; University of California, Los Angeles; University... and other collaborators

Active, not recruiting

Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype

Glioma | Recurrent Malignant Glioma

United States
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; Novartis Pharmaceuticals; University of California,... and other collaborators

Completed

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

Fibrolamellar Carcinoma | Fibrolamellar Liver Cancer

United States
Dana-Farber Cancer Institute
Columbia University; Boston Children's Hospital; McMaster University; University... and other collaborators

Completed

Treatment of Acute Lymphoblastic Leukemia in Children

Acute Lymphoblastic Leukemia

United States
Pack Health
M.D. Anderson Cancer Center; The University of Texas Health Science Center,... and other collaborators

Recruiting

Comprehensive Outcomes for After Cancer Health (COACH)

Breast Cancer | Gastric Cancer | Ovarian Cancer | Lung Cancer | Survivorship

United States
CVSS study
Univ. Prof. Dr. med. Joerg Faber, Center for Pediatrics, Hematology, Oncology... and other collaborators

Active, not recruiting

Cardiac and Vascular Late Sequelae in Long-term Survivors of Childhood Cancer (CVSS) (CVSS)

Childhood and Adolescence Cancer (Survivors and Deceased)

Germany
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center; Mayo Clinic; Dana-Farber Cancer Institute; Duke University and other collaborators

Active, not recruiting

Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes

Leukemia

United States
Patrick Y. Wen, MD
Memorial Sloan Kettering Cancer Center; Massachusetts General Hospital; Northwestern... and other collaborators

Completed

Monthly SOM230C for Recurrent or Progressive Meningioma

Meningioma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Washington... and other collaborators

Active, not recruiting

Improving Outcomes Assessment in Chronic GVHD

Chronic Graft Versus Host Disease

United States
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; M.D. Anderson Cancer Center; University of Colorado... and other collaborators

Completed

External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas

Brain Cancer

United States, Canada
Central Hospital, Nancy, France
Sanofi; GlaxoSmithKline; Zambon SpA; Laboratoires URGO; Pierre Fabre Medicament; Bi... and other collaborators

Unknown

Allergy to Neuromuscular Blocking Agents and Pholcodine Exposure (ALPHO)

Neuromuscular Blocking Agents Anaphylaxis

France
Dana-Farber Cancer Institute
Johns Hopkins University; Washington University School of Medicine; National... and other collaborators

Completed

Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease

Sickle Cell Disease

United States
Patrick Y. Wen, MD
M.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts... and other collaborators

Completed

Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma

Glioblastoma

United States
Oslo University Hospital
Massachusetts General Hospital; Dana-Farber Cancer Institute; University Medical... and other collaborators

Active, not recruiting

Improved Therapy Response Assessment in Metastatic Brain Tumors (TREATMENT)

Brain Metastases

Norway
Rigshospitalet, Denmark
Dana-Farber Cancer Institute; St. Jude Children's Research Hospital; European... and other collaborators

Completed

Second Malignant Neoplasms After Childhood ALL Therapy (PdL-SMN1)

Acute Lymphoblastic Leukemia

Denmark

Clinical Trials Sponsored by Jens Faber

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations